GFH009 Clinical Trials
2 recruitingDrug
Phase 12Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study of GFH009 in Combination With Zanubrutinib in Subjects With Relapsed or Refractory DLBCL
Large B-cell Lymphoma
Genfleet Therapeutics (Shanghai) Inc.51 enrolled2 locationsNCT06375733
Recruiting
Phase 1Phase 2
A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Genfleet Therapeutics (Shanghai) Inc.95 enrolled1 locationNCT05934513